Startup India Government of India
Everest Life Sciences Private Limited
Everest Life Sciences Private Limited - trading in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.55 Lakh
Latest filing
Net loss · FY 2025
₹82,985
Net margin -23.4%
EBITDA · FY 2025
₹5.88 Lakh
EBITDA margin 165.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Everest Life Sciences Private Limited
Data last updated:
Everest Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 29 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2017PTC117395. Its GSTIN is 36AAGCT2804G1ZI (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Tarini Research Center Private Limited and Eve-Rest Research Center Private Limited. It is led by directors Srikakarlapudi Sirisha and Krishna Veni Srikakarlapudi.
Its last annual general meeting (AGM) was held on 06 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.55 Lakh. For the same year it recorded a net loss of ₹82,985 (net margin -23.4%) and EBITDA of ₹5.88 Lakh (EBITDA margin 165.8%).
Everest Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0005279). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909TG2017PTC117395
Registration Number 117395
Incorporation Date 29 May 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 06 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0005279
Name history
Everest Life Sciences has undergone 6 name changes throughout its history. The current legal name is Everest Life Sciences Private Limited.
| Company Name | Status |
|---|---|
| Everest Life Sciences Private Limited | Current |
| Tarini Research Center Private Limited | Previous |
| Eve-Rest Research Center Private Limited | Previous |
| Everest R&D Private Limited | Previous |
| Eve-Rest Pharmatech Private Limited | Previous |
| Tarini Pharmatech Private Limited | Previous |
| Everest Pharma Private Limited | Previous |
Recognitions & Rankings of Everest Life Sciences
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-20-0005279
Contact details
Everest Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressIndo Engg. Products Second Floor 5B Type – II Tsiic I.E. Prashanthi Nagar Kukatpall, Y, Hyderabad, Telangana, India – 500072
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Everest Life Sciences Private Limited, buy the company report.
Comprehensive company report
Everest Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Everest Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Everest Life Sciences Private Limited
FY 2025 filings availableEverest Life Sciences Private Limited reported revenue of ₹3.55 Lakh for FY 2025.
Revenue · FY 2025
₹3.55 Lakh
Net loss · FY 2025
₹82,985 margin -23.4%
EBITDA · FY 2025
₹5.88 Lakh margin 165.8%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹82,985 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 165.8% | ||||
| Net Profit Margin | -23.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Everest Life Sciences Private Limited, buy the company report.
Board of directors of Everest Life Sciences Private Limited
Everest Life Sciences has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srikakarlapudi Sirisha Also directs: Everest Organics Limited | Director | 29 May 2017 | 9 Years 5 Months | Current |
| Krishna Veni Srikakarlapudi Also directs: Veerat Finance and Investment Limited | Director | 29 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Everest Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lixue Brands Private Limited | ₹3.6 Lakh (FY 2024) | -31.0% | Indore, Madhya Pradesh, India | |||
| Anasia Lab Private Limited | ₹3.57 Lakh (FY 2024) | 22.0% | Nalgonda, Telangana, India | |||
| Adrene Prime Private Limited | ₹3.56 Lakh (FY 2024) | New Delhi, Delhi, India | ||||
| Bionor Pharmaceuticals Private Limited | ₹3.56 Lakh (FY 2025) | -58.0% | Hyderabad, Telangana, India | |||
| Orrah Pharmaceutical Private Limited | ₹3.55 Lakh (FY 2018) | -34.0% | Lucknow, Uttar Pradesh, India | |||
| Everest Life Sciences Private Limitedthis company | ₹3.55 Lakh (FY 2025) | -₹82,985 | -23.4% | Hyderabad, Telangana, India | ||
| Ora Life Sciences Private Limited | ₹3.55 Lakh (FY 2023) | 57.0% | Delhi, India | |||
| Medicfibers Private Limited | ₹3.55 Lakh (FY 2022) | 138.0% | Patna, Bihar, India | |||
| Wefas Ayurvedic Private Limited | ₹3.55 Lakh (FY 2024) | 93.0% | Nashik, Maharashtra, India | |||
| Shree Ganeshaa Chemicals Private Limited | ₹3.54 Lakh (FY 2025) | -99.0% | New Delhi, Delhi, India | |||
| Staywell Formulation Private Limited | ₹3.54 Lakh (FY 2024) | -100.0% | New Delhi, Delhi, India |
To see the full peer comparison of Everest Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Everest Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Everest Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Everest Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCT2804G1ZI | Telangana | Active | 01 Jun 2018 |
To see the full GST registrations and return filing status of Everest Life Sciences Private Limited, buy the company report.
Recent activity
Everest Life Sciences Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Krishna Veni Srikakarlapudi was appointed as Director on 29 May 2017.
AGM
Everest Life Sciences Private Limited last Annual general meeting of members was held on 06 Sep 2025 as per latest MCA records.
Filing
Everest Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Krishna Veni Srikakarlapudi was appointed as Director.
Appointed
Srikakarlapudi Sirisha was appointed as Director.
Incorporation
29 May 2017
Everest Life Sciences Private Limited was registered on 29 May 2017 with Roc Hyderabad & aged 9 years 5 months as per MCA records.
Frequently asked questions
Everest Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 29 May 2017 (9+ years old) and is registered under CIN U51909TG2017PTC117395.
Everest Life Sciences has 2 current directors:
- Srikakarlapudi Sirisha - Director
- Krishna Veni Srikakarlapudi - Director
The latest financial statements of Everest Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 06 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Everest Life Sciences is 36AAGCT2804G1ZI, registered in Telangana.
The CIN (Corporate Identification Number) of Everest Life Sciences is U51909TG2017PTC117395. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Everest Life Sciences was incorporated on 29 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Everest Life Sciences by revenue are Lixue Brands Private Limited, Anasia Lab Private Limited, Adrene Prime Private Limited, Bionor Pharmaceuticals Private Limited, Orrah Pharmaceutical Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Krishna Veni Srikakarlapudi was appointed as Director on 29 May 2017. Srikakarlapudi Sirisha was appointed as Director on 29 May 2017.
Yes, Everest Life Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Everest Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0005279).
The registered office of Everest Life Sciences is at Indo Engg. Products Second Floor 5B Type – II Tsiic I.E. Prashanthi Nagar Kukatpall, Y, Hyderabad, Telangana, India – 500072.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages